Basher, F., Visentin, J., Jia, W., Poe, J. C., Su, H., Sofian, C., … Sarantopoulos, S. (2023). The DNA Sensor AIM2 Promotes BCR-Activated B Cells in Chronic Graft-Versus-Host-Disease. Transplantation and Cellular Therapy, 29(2), S58–S59. https://doi.org/10.1016/s2666-6367(23)00138-0

Basher, Fahmin, Jonathan Visentin, Wei Jia, Jonathan C. Poe, Hsuan Su, Christina Sofian, Rachel DiCioccio, et al. “The DNA Sensor AIM2 Promotes BCR-Activated B Cells in Chronic Graft-Versus-Host-Disease.” Transplantation and Cellular Therapy 29, no. 2 (February 2023): S58–59. https://doi.org/10.1016/s2666-6367(23)00138-0.

Basher F, Visentin J, Jia W, Poe JC, Su H, Sofian C, et al. The DNA Sensor AIM2 Promotes BCR-Activated B Cells in Chronic Graft-Versus-Host-Disease. Transplantation and Cellular Therapy. 2023 Feb;29(2):S58–9.

Basher, Fahmin, et al. “The DNA Sensor AIM2 Promotes BCR-Activated B Cells in Chronic Graft-Versus-Host-Disease.” Transplantation and Cellular Therapy, vol. 29, no. 2, Elsevier BV, Feb. 2023, pp. S58–59. Crossref, doi:10.1016/s2666-6367(23)00138-0.

Basher F, Visentin J, Jia W, Poe JC, Su H, Sofian C, DiCioccio R, Curry-Chisolm I, Bracken S, Ho VT, Sisirak V, Horwitz ME, Chao NJ, Sarantopoulos S. The DNA Sensor AIM2 Promotes BCR-Activated B Cells in Chronic Graft-Versus-Host-Disease. Transplantation and Cellular Therapy. Elsevier BV; 2023 Feb;29(2):S58–S59.